Epidermal growth factor + growth hormone-releasing peptide 6

Epidermal growth factor + growth hormone-releasing peptide 6 has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 4, 2026: “EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences”.

Intervention

1 paper studies it5 findingsUpdated

See all 1 papers on epidermal growth factor + growth hormone-releasing peptide 6

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

What did studies of epidermal growth factor + growth hormone-releasing peptide 6 find?

5

Studies of epidermal growth factor + growth hormone-releasing peptide 6 measured 5 outcomes, among them HMOX1, NFKB1 and working memory.

HMOX1

upin mice1

1 study
  1. Epidermal growth factor + growth hormone-releasing peptide 6 increases HMOX1 in mice.

    “EGF + GHRP6 treatment significantly increased the expression of genes associated with antioxidant defense (Hmox1)”

    Animals

    EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences

    Neurotoxicity research

More on HMOX1

NFKB1

downin mice1

1 study
  1. Epidermal growth factor + growth hormone-releasing peptide 6 decreases NFKB1 in mice.

    “while concurrently reducing the expression of Nfkb1.”

    Animals

    EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences

    Neurotoxicity research

More on NFKB1

Working memory

upin mice1

1 study
  1. Epidermal growth factor + growth hormone-releasing peptide 6 improves working memory in streptozotocin-induced cognitive impairment mice.

    “STZ-EGF + GHRP6 group exhibited an alternation percentage higher than the STZ-vehicle group (p = 0.03).”

    Animalsin streptozotocin-induced cognitive impairment mice

    EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences

    Neurotoxicity research

Spatial memory

upin mice1

1 study
  1. Epidermal growth factor + growth hormone-releasing peptide 6 improves spatial memory in aged mice.

    “In the forced alternation Y-maze test, aged-EGF + GHRP6 animals made more visits to the novel arm than to the familiar arm 1 (p = 0.001) or to the familiar arm 2 (p = 0.04).”

    Animalsin aged mice

    EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences

    Neurotoxicity research

Step length

upin mice1

1 study
  1. Epidermal growth factor + growth hormone-releasing peptide 6 improves step length in aged mice.

    “In aged animals, EGF + GHRP6 treatment increased step length (p = 0.04).”

    Animalsin aged mice

    EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences

    Neurotoxicity research

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months